Objective:To investigate the association of serum levels of micro RNA-126(miR-126),C-peptide,secreted phospholipase A2(sPLA2)with carotid atherosclerotic plaque(CAP)and prognosis in patients with coronary heart disease(CHD).Methods:A total of 114 patients with carotid atherosclerotic coronary heart disease(CAS-CHD)admitted to-Baoding Third Central Hospital between February 2020 and February 2021 were enrolled.Patients were divided into stable plaque group(n=68)and unstable plaque group(n=46)according to carotid ultrasound findings.Serum levels of miR-126,C-peptide and sPLA2 were compared between two groups.Pearson correlation analysis was used to determine the as-sociation of miR-126,C-peptide and sPLA2 with plaque Crouse score.Binary Logistic regression analysis was used to in-vestigate the association of miR-126,C-peptide and sPLA2 with unfavorable outcome.The predictive performance of the combined detection of miR-126,C-peptide,and sPLA2 for unfavorable outcome in CAS-CHD patients was evalua-ted using the receiver operating characteristic(ROC)curve analysis.Results:Compared with patients in the stable plaque group,those in the unstable plaque group had significant higher miR-126[(0.99±0.30)vs.(0.81±0.24)],carotid inti-ma-media thickness(IMT)[(1.67±0.42)mm vs.(1.31±0.51)mm]and plaque Crouse score[(5.93±1.42)points vs.(4.30±1.32)points](P＜0.001 all).Pearson correlation analysis indicated that miR-126,C-peptide and sPLA2 were positively correlated with plaque Crouse score(r=0.267,0.309,0.351,P＜0.01 all).Binary Logistic regression a-nalysis showed that age[odds ratio(OR)=1.509,95％CI 1.055～2.157],miR-126(OR=60.595,95％CI 1.252～2932.237),C-peptide(OR=2.870,95％CI 1.249～6.595),sPLA2(OR=1.068,95％CI 1.016～1.124)and plaque Crouse score(OR=4.491,95％CI 1.824～11.059)were independently associated with unfavorable outcome(P＜0.05 or＜0.01).The area under the joint prediction curve(AUC)was 0.898(95％CI 0.825～0.948),which was significantly higher than miR-126(AUC=0.722,95％CI 0.628～0.804),C-peptide(AUC=0.818,95％CI 0.732～0.886)and sPLA2(AUC=0.806,95％CI 0.719～0.876)alone(Z=3.140,3.161,2.930,P＜0.01 all).Conclusion:Serum miR-126,C-peptide and sPLA2 levels were significantly correlated with the severity of carotid atherosclerosis in coronary heart disease.Combined detection of these three biomarkers may predict unfavorable outcome in these patients.

Objective:To investigate the clinical efficacy of levocarnitine combined with fructose 1,6-diphosphate(FDP)on patients with viral myocarditis(VMC)and its effect on serum levels of aspartate aminotransferase(AST),lactate dehydrogenase(LDH)and cardiac troponin I(cTnI).Methods:This randomized controlled study enrolled 126 patients with VMC admitted to Xingyuan Hospital of Yulin between May 2020 and August 2021.Pa-tients were divided into control group(n=63)and intervention group(n=63).Patients in the control group re-ceived routine treatment comparing to those in the intervention group receiving additional FDP combined with levoc-arnitine,both groups were treated for 4 weeks.Left ventricular ejection fraction(LVEF),levels of AST,LDH,cTnI,creatine kinase(CK),creatine kinase isoenzyme MB(CK-MB)and therapeutic effective rate were com-pared between the two groups.Pearson correlation analysis was used to analyze the association of AST,LDH,cTnI levels with LVEF.Results:Compared with patients in control group after 4-week treatment,those in the inter-vention group had significant higher LVEF[(73.17±6.39)％vs.(63.30±6.04)％]and therapeutic effective rate(96.67％vs.80.00％)(P＜0.001 all),and significant lower levels of AST[(32.35±7.34)U/L vs.(48.22±8.40)U/L],LDH[(154.50±28.10)U/Lvs.(183.77±29.60)U/L],cTnI[(77.47±12.04)ng/ml vs.(96.12±15.33)ng/ml],CK[(181.47±8.93)U/L vs.(192.33±8.85)U/L],CK-MB[(24.25±2.19)U/L vs.(28.17±2.01)U/L](P＜0.001 all).Pearson correlation analysis indicated that AST,LDH and cTnI levels were significant negatively correlated with LVEF(r=-0.404,-0.231,-0.339,P＜0.05 or＜0.01).There was no significant difference in the incidence of adverse reactions between the two groups(P=0.543).Conclusion:FDP combined with levocarnitine could significantly improve cardiac function,reduce the levels of AST,LDH and cTnI,and effectively improve therapeutic effective rate with good safety in patients with viral myocarditis.

Objective:To explore the effect of ezetimibe combined with atorvastatin on the efficacy,blood lipids,ca-rotid ultrasound indicators in patients with coronary heart disease(CHD)and its safety.Methods:This randomized controlled study enrolled 98 CHD patients admitted to 945th Hospital of the PLA Joint Logistic Support Force be-tween June 2021 and June 2023.Patients were divided into intervention group and control group with 49 cases in each group.Patients in the control group was treated with atorvastatin-bascd routine medication comparing to those in intervention group receiving additional ezetimibe,both groups were treated for 90 d.Clinical efficacy,blood lipids,carotid ultrasound indicators,endothelial function indicators,and incidence of adverse reactions were compared between two groups.Results:Compared with patients in the control group,those in the intervention group had significant higher total effective rate(91.83％vs.73.47％,P=0.016).Compared with patients in the control group after treatment,those in intervention group had significant lower levels of low density lipoprotein cho-lesterol(LDL-C)[(2.74±0.61)mmol/L vs.(3.42±0.66)mmol/L],total cholesterol(TC)[(3.80±0.89)mmol/L vs.(4.69±1.02)mmol/L],triglyceride(TG)[(1.79±0.53)mmol/L vs.(2.35±0.62)mmol/L],re-sistance index(RI)[(52.02±6.32)％vs.(57.95±6.02)％],carotid intima-media thickness(IMT)[(0.91±0.17)mm vs.(1.08±0.24)mm],von Willebrand factor(vWF)[(19.03±3.76)mg/L vs.(23.41±4.42)mg/L],angiotensin Ⅱ(Ang Ⅱ)[(45.83±5.87)ng/L vs.(52.87±6.01)ng/L](P＜0.001 all);and significant high-er high density lipoprotein cholesterol(HDL-C)[(1.63±0.32)mmol/L vs.(1.35±0.27)mmol/L],peak systol-ic velocity(PSV)[(47.93±5.26)cm/s vs.(41.32±4.98)cm/s],end-diastolic velocity(EDV)[(36.14±5.10)cm/s vs.(30.73±4.48)cm/s],pulse index(PI)[(85.98±9.03)％vs.(78.42±8.82)％],vascular endothelial growth factor receptor 1(VEGFR1)[(289.14±32.98)ng/L vs.(258.34±29.32)ng/L](P＜0.001 all).There was no significant difference in the incidence of adverse reactions between the two groups(P=0.538).Conclusion:Ezetimibe combined with atorvastatin possesses significant therapeutic effect on CHD patients,which could signifi-cantly reduce blood lipids,improve the carotid blood flow velocity and vascular endothelial function with good safety.

Objective:Based on the dataset in the Gene Expression Omnibus database(GEO),we screened out the co-expression modules most relevant to acute myocardial infarction(AMI)and identified ferroptosis-related bio-markers.Methods:We constructed a weighted gene co-expression network for the hypervariable genes in the GSE123342 dataset,screened out the gene modules most related to AMI and identified ferroptosis-related biomark-ers from the key modules,and then observed their expression levels in tissues as well as further analyzed their corre-lation with the immune microenvironment.Results:One key module most relevant to AMI patients was obtained.By intersecting with differential genes,a total of 532 differential genes that were up-regulated in AMI were ob-tained.Functional enrichment analysis showed that they were mainly enriched in biological processes such as granu-locyte migration,reactive oxygen species generation,leukocyte chemotaxis and activation,and defense response regulation.The pathways were mainly enriched in Toll-like signaling pathway,nuclear factor kappa B(NF-κB)signaling pathway,tumor necrosis factor(TNF)signaling pathway,hypoxia-inducible factor-1(HIF-1)signa-ling pathway and cytokine-cytokine receptor interaction pathways,etc.Finally,14 genes were found that were promising targets for AMI treatment:zinc finger antisense 1(ZFAS1),WD repeat domain,phosphoinositide inter-acting 1(WIPI1),Toll-like receptor 4(TLR4),quiescin sulfhydryl oxidase 1(QSOX1),phosphatase and tensin homolog(PTEN),phosphogluconate dehydrogenase(PGD),mitochondrial fusion protein 2(MFN2),double mi-nute 2 homolog(MDM2),mitogen-activated protein kinase 14(MAPK14),mitogen-activated protein kinase 1(MAPK1),gamma-aminobutyric acid receptor-associated protein-like 1(GABARAPL1),arachidonate 5-li-poxygenase(ALOX5),long-chain acyl-CoA synthetase 4(ACSL4),and long-chain acyl-CoA synthetase 1(ACSL1).Correlation analysis revealed that they all had obvious correlations with various immune cells.Conclusion:The 14 ferroptosis genes associated with AMI are expected to become potential immunotherapy targets.

Objective:To explore the effect of combined comprehensive geriatric assessment(CGA)and medical con-joined hierarchical diagnosis and treatment in patients with chronic pulmonary heart disease(CPHD).Methods:This randomized controlled study enrolled 173 CPHD patients treated in the First Affiliated Hospital of Xinjiang Medical University between January 2021 and June 2023,and patients were divided into intervention group(n=86)and control group(n=87).Patients in the control group received the routine diagnosis and treatment process man-agement,and those in the intervention group received the CGA combined with medical conjoined hierarchical diag-nosis and treatment.Both groups were intervened for 1 month,and the curative effect,referral situation,incidence of adverse cardiac events,falls,score of Adult Health Self-Management Scale Revised Version(AHSMSRS),stroke volume(SV),left ventricular ejection fraction(LVEF),forced expiratory volume in one second(FEV1),the ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC)and medical coping modes questionnaire(McMQ)score were compared between two group safter intervention.Results:Compared with pa-tients in control group,those in intervention group had significant higher curative effect(92.00％vs.80.00％),proportion of referral to the primary hospital(62.67％vs.26.67％),SV[(62.41±1.83)ml vs.(56.15±2.24)ml],LVEF[(58.48±0.83)％vs.(54.14±0.71)％],FEV1[(1.82±0.18)L vs.(1.41±0.06)L],FEV1/FVC[(78.19±1.96)％vs.(68.85±2.10)％],confronce score[(16.92±0.83)points vs.(14.93±0.83)points]of McMQ,significant lower avoidance score[(9.01±0.85)points vs.(11.91±0.83)points]of McMQ,significant higher dimensional scores of AHSMSRS(P＜0.001 all),and significant lower incidence of cardiac adverse events(9.33％vs.22.67％)and falls(8.00％vs.20.00％)(P＜0.05 both).Conclusion:The implementation of CGA combined with medical conjoined hierarchical diagnosis and treatment for CPHD patients may effectively improve the curative effect and hospital referral.It indirectly enhances the self-management ability and cardiopulmonary function,and helps to reduce the risk of cardiac adverse events and falls.

Objective:This study aimed to explore the mediating effect of resourcefulness between frailty and self-manage-ment efficacy in patients with chronic heart failure(CHF).Methods:A survey was conducted on CHF patients who ad-mitted in Department of Cardiology,Central Hospital Affiliated to Shandong First Medical University between May 2022 and March 2024 using the general formation questionnaire,Tilburg weakness assessment scale,Resourcefulness Scale(RS)and Self-Efficacy for Managing Chronic Disease 6-item scale(SEMCD6).Results:Age,employment,marriage,ACC/AHA cardiac function classification,exercise frequency,and comorbid chronic diseases affected the level of frailty in pa-tients;Employed or not affected the patient's resourcefulness level(P＜0.05 or＜0.01).Multivariate linear regression and Spearman correlation analysis showed that frailty was direct negative predictive effect(β=-1.029,P=0.019)and in-versely correlated(r=-0.155,P=0.016)with self-management efficacy;resourcefulness was direct positive predictive effect(β=0.150,P＜0.001)and positively correlated(r=0.336,P＜0.001)with it.Resourcefulness played a partial mediating effect between frailty and self-management efficacy(21.93％).Conclusion:Resourcefulness level plays a par-tial mediating role between frailty and self-management efficacy in patients with chronic heart failure.Medical staff should pay attention to early screening and intervention of resourcefulness level.

Objective:To study microRNA-708(miR-708)expression and level of CXC chemokine ligand 13(CX-CL13)in patients with acute myocardial infarction(AMI)and their association.Methods:A total of 60 AMI pa-tients treated in Department of Cardiology,Shanghai Fengxian District Central Hospital between May 2020 and May 2023 were selected as AMI group,another 60 healthy subjects who simultaneously underwent physical examination were regarded as healthy control group.Serum miR-708 expression,levels of CXCL13,creatine kinase isoenzyme MB(CK-MB)and cardiac troponin I(cTnI)were measured.The association of miR-708,CXCL13 with CK-MB and cTnI in AMI patients was analyzed by Pearson correlation analysis.Receiver operating characteristic(ROC)curve was used to analyze diagnostic value of miR-708 and CXCL13 for AMI.Results:Compared with participants in the healthy control group,those in AMI group had significant lower miR-708 expression[(0.54±0.17)vs.(1.05±0.36)],and significant higher levels of CXCL13[(72.44±13.18)pg/ml vs.(48.16±5.72)pg/ml],cTnI[(6.07±2.12)ng/ml vs.(1.77±0.25)ng/ml]and CK-MB[(62.43±12.42)U/L vs.(14.35±3.61)U/L](P＜0.001 all).Pearson correlation analysis revealed a significant inverse correlation of miR-708 expression with CXCL13,cTnI and CK-MB(r=-0.687,P＜0.001;r=-0.559,P＜0.001;r=-0.588,P＜0.001);and a significant positive correlation of CXCL13 level with cTnI and CK-MB(r=0.598,P＜0.001;r=0.580,P＜0.001).ROC curve analysis indicated that the area under the curve(AUC)of miR-708 expression,CXCL13 level and their combination for diagnosing AMI was 0.833(95％0.753～0.912),0.844(95％0.766～0.922)and 0.946(95％0.897～0.995)respectively,and AUC of the combined detection was significantly higher than those of single detections(Z=2.353,2.162,P=0.019,0.031).Conclusion:The expression of miR-708 significantly decreases and CXCL13 level sig-nificantly increases in AMI patients.Their combined detection possess certain diagnostic value for AMI.

Objective:To investigate the factors influencing left atrial fibrosis in patients with atrial fibrillation(AF)and the association of Periostin protein,serum transforming growth factor-β2(TGF-β2)with left atrial fibrosis.Methods:We enrolled 100 AF patients admitted to Gansu Provincial People's Hospital between March 2021 and March 2023.They were divided into control group(＜10％,n=53)and fibrosis group(≥10％,n=47)according to their left atrial low voltage region.Univariate and multivariate Logistic regression were used to analyze the influ-encing factors of left atrial fibrosis in AF patients and construct a nomogram model.The diagnostic value of related factors and their combined detection for left atrial fibrosis in AF patients were analyzed by receiver operating char-acteristic curve(ROC).Spearman correlation analysis was used to analyze the association of Periostin protein,TGF-β2 with left atrial fibrosis in AF patients.Results:Compared to patients in the control group,those in the fibrosis group had significant higher left atrial diameter(LAD)[(37.08±3.19)mm vs.(33.45±2.45)mm],levels of ser-um uric acid(SUA)[(313.75±49.06)μmol/L vs.(279.88±38.15)μmol/L],Periostin protein[(83.27±3.98)ng/L vs.(75.21±3.04)ng/L],TGF-β2[(4346.84±321.34)ng/L vs.(4186.02±306.91)ng/L],and signifi-cant lower left atrial ejection fraction(LVEF)[(62.28±5.00)％vs.(67.24±3.07)％](P＜0.05 or＜0.01).Multivariate Logistic regression analysis showed that LAD(OR=1.663,95％CI 1.238～3.887,P=0.001),SUA(OR=1.586,95％CI 1.164～2.892,P＜0.001),Periostin protein(OR=1.997,95％CI 1.513～4.585,P=0.001),TGF-β2(OR=2.013,95％CI 1.543～5.864,P＜0.001)were independent risk factors for left atrial fi-brosis in AF patients,while LVEF was an independent protective factor(OR=0.524,95％CI 0.141～0.920,P=0.002).The nomogram model for left atrial fibrosis in AF patients:logit(P)=4.631+0.445 × LVEF+0.546 × LAD+0.575 × SUA+0.530 × Periostin protein+0.347 × TGF-β2.ROC curve showed that the area under the curve(AUC)of combined detection(0.893,95％CI 0.842～0.932)was significantly higher than SUA(AUC=0.637,95％CI 0.566～0.704),LVEF(AUC=0.701,95％CI 0.632～0.763),LAD(AUC=0.649,95％CI 0.579～0.715),Periostin protein(AUC=0.676,95％CI 0.606～0.740),TGF-β2(AUC=0.641,95％CI 0.570～0.707)alone(Z=5.265,6.399,6.379,6.040,6.483,P＜0.001 all).Spearman correlation analysis showed that Perios-tin protein and TGF-β2 were significantly positive correlated with left atrial fibrosis in AF patients(r=0.536,0.578,P＜0.001 all).Conclusion:Periostin protein and TGF-β2 were independent risk factors for left atrial fi-brosis in AF patients and were significantly positive correlated with it,a combination of above-mentioned indexes,cardiac function indexes and uric acid had good diagnostic value for left atrial fibrosis.

Objective:To investigate the effect of graded rehabilitation intervention on cardiac function,self-man-agement ability,exercise tolerance,sleep quality and quality of life in patients with chronic heart failure(CHF).Methods:This randomized controlled study enrolled 125 patients with CHF admitted to Lu'an People's Hospital be-tween April 2020 and October 2023.Patients were divided into control group(n=62)and intervention group(n=63).Participants in the control group received routine rehabilitation intervention,while those in the intervention group received additional graded rehabilitation intervention.Both groups were intervened for 3 months.Cardiac function indexes,6min walking distance(6MWD),metabolic equivalent(METs),scores of exercise of self-care a-gency(ESCA),Pittsburgh sleep quality index(PSQI)and the MOS item short from health survey(SF-36),and in-cidence of adverse events during the intervention were compared between the two groups.Results:Compared to pa-tients in the control group,those in intervention group had significant lower left ventricular end-diastolic volume(LVEDV)[(108.19±2.96)ml vs.(129.51±3.34)ml],left ventricular end-systolic volume(LVESV)[(50.68±2.28)ml vs.(67.38±2.68)ml],score of Pittsburgh sleep quality index(PSQI)[(8.30±1.87)points vs.(13.99±2.06)points](P＜0.001 all),and significant higher left ventricular ejection fraction(LVEF)[(58.17±2.08)％vs.(50.70±1.63)％],ESCA score[(148.29±19.48)points vs.(124.68±15.93)points],6MWD[(413.58±15.11)m vs.(372.22±14.62)m],METs[(6.88±0.64)kcal·kg-1·h-1 vs.(6.13±0.62)kcal·kg-1·h-1],total SF-36 score[(128.97±6.62)points vs.(104.35±5.46)points](P＜0.001 all).The inci-dence of adverse events in the intervention group was significantly lower than that in the control group(5.00％vs.18.33％,P=0.023).Conclusion:The graded rehabilitation intervention may improve the heart function,self-management ability,exercise tolerance,sleep quality and quality of life in CHF patients,and has high safety.

Objective:To explore the effect of Wuqinxi combined with resistance training on cardiac function and self-care ability in patients with chronic heart failure(CHF).Methods:This randomized controlled study enrolled 152 CHF patients admitted to Nanjing Hospital of Chinese Medicine between September 2018 and December 2022.Pa-tients were divided into control group(n=76)and intervention group(n=76).Patients in control group received routine intervention measure combined resistance training,while those in the intervention group received additional Wuqinxi.Both groups were intervened for 6 months.The clinical total effective rate,cardiac function,self-care ability and quality of life were compared between two groups.We also compared the incidence of adverse events and readmission rate during 6-month follow-up.Results:The total effective rate of the intervention group was sig-nificantly higher than that of the control group(93.2％vs.81.1％,P=0.003).Compared with patients in the control group,those in the intervention group had significant higher left ventricular ejection fraction(LVEF)[(50.08±8.37)％vs.(43.47±8.02)％]and 6min walking distance(6MWD)[(496.76±40.54)m vs.(406.76±28.65)m](P＜0.001 both);and significant lower left ventricular end-diastolic volume(LVEDV)[(109.82±9.90)ml vs.(165.29±12.26)ml],left ventricular end-systolic volume(LVESV)[(59.09±2.69)ml vs.(72.61±3.54)ml],score of the European Heart Failure Self-care Behaviour Scale(EHFScBS)[(26.49±3.24)points vs.(35.80±4.33)points],and Minnesota Living with Heart Failure Questionnaire(MLHFQ)total score[(43.78±4.50)points vs.(56.55±4.92)points](P＜0.001 all).The total incidence of adverse events(2.8％vs.12.3％)and readmission rate(1.4％vs.11.0％)in the intervention group were significantly lower than those of the control group(P＜0.05 both).Conclusion:Wuqinxi combined with resistance training may improve clinical efficacy,cardiac function,self-care ability,reduce incidence of adverse events and readmission,then improve quality of life in CHF patients.